{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:20:25Z","timestamp":1788272425153,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05407-0","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:34:26Z","timestamp":1786642466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic implications and precision selection criteria of primary tumor resection in metastatic gallbladder adenocarcinoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Xun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"issue":"8","key":"5407_CR1","doi-asserted-by":"publisher","first-page":"e583","DOI":"10.1016\/S2468-2667(24)00156-7","volume":"9","author":"H Sung","year":"2024","unstructured":"Sung H, Jiang C, Bandi P, et al. Differences in cancer rates among adults born between 1920 and 1990 in the USA: an analysis of population-based cancer registry data. Lancet Public Health. 2024;9(8):e583\u201393.","journal-title":"Lancet Public Health"},{"issue":"5","key":"5407_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.14309\/ajg.0000000000001151","volume":"116","author":"D Kim","year":"2021","unstructured":"Kim D, Konyn P, Cholankeril G, et al. Trends in the Mortality of Biliary Tract Cancers Based on Their Anatomical Site in the United States From 2009 to 2018. Am J Gastroenterol. 2021;116(5):1053\u201362.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"5407_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13023-025-03652-0","volume":"20","author":"A Afzal","year":"2025","unstructured":"Afzal A, Liu YY, Noureen A, et al. Epidemiology of gall bladder cancer and its prevalence worldwide: a meta-analysis. Orphanet J Rare Dis. 2025;20(1):143.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"5407_CR4","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1002\/ijc.35232","volume":"156","author":"M Pi\u00f1eros","year":"2025","unstructured":"Pi\u00f1eros M, Vignat J, Colombet M, et al. Global variations in gallbladder cancer incidence: What do recorded data and national estimates tell us? Int J Cancer. 2025;156(7):1358\u201368.","journal-title":"Int J Cancer"},{"issue":"1","key":"5407_CR5","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"5407_CR6","first-page":"101242","volume":"56","author":"HY Ko","year":"2025","unstructured":"Ko HY, Bea S, Yoon D, et al. Incretin-based drugs and the risk of gallbladder or biliary tract diseases among patients with type 2 diabetes across categories of body mass index: a nationwide cohort study. Lancet Reg Health West Pac. 2025;56:101242.","journal-title":"Lancet Reg Health West Pac"},{"key":"5407_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2024.09.011","author":"JJ He","year":"2024","unstructured":"He JJ, Xiong WL, Sun WQ, et al. Advances and current research status of early diagnosis for gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2024. https:\/\/doi.org\/10.1016\/j.hbpd.2024.09.011.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"5407_CR8","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5407_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5582\/bst.2020.01039","volume":"15","author":"H Cheng","year":"2021","unstructured":"Cheng H, Zhou D, Wang S, et al. The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practices. Biosci Trends. 2021;15(1):9\u201315.","journal-title":"Biosci Trends"},{"issue":"24","key":"5407_CR10","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1158\/1078-0432.CCR-22-1954","volume":"28","author":"NA Giraldo","year":"2022","unstructured":"Giraldo NA, Drill E, Satravada BA, et al. Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention. Clin Cancer Res. 2022;28(24):5359\u201367.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"5407_CR11","doi-asserted-by":"publisher","first-page":"13063","DOI":"10.1002\/cam4.5983","volume":"12","author":"Z Li","year":"2023","unstructured":"Li Z, Zheng H, Zhao Z, et al. Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching. Cancer Med. 2023;12(12):13063\u201375.","journal-title":"Cancer Med"},{"issue":"1","key":"5407_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.21037\/tlcr-20-709","volume":"10","author":"H Liang","year":"2021","unstructured":"Liang H, Liu Z, Huang J, et al. Identifying optimal candidates for primary tumor resection among metastatic non-small cell lung cancer patients: a population-based predictive model. Transl Lung Cancer Res. 2021;10(1):279\u201391.","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"5407_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.pan.2022.01.004","volume":"22","author":"Z Lu","year":"2022","unstructured":"Lu Z, Shao W, Shi X, et al. Identifying optimal candidates for tumor resection amongborderline and locally advanced pancreatic cancer: A population-based predictive model. Pancreatology. 2022;22(2):286\u201393.","journal-title":"Pancreatology"},{"issue":"11","key":"5407_CR14","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1210\/clinem\/dgae214","volume":"109","author":"CQ Liu","year":"2024","unstructured":"Liu CQ, Shen CK, Du YX, et al. Survival Outcome and Optimal Candidates of Primary Tumor Resection for Patients With Metastatic Medullary Thyroid Cancer. J Clin Endocrinol Metab. 2024;109(11):2979\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5407_CR15","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.suc.2024.03.006","volume":"104","author":"GC Waller","year":"2024","unstructured":"Waller GC, Sarpel U. Gallbladder Cancer. Surg Clin North Am. 2024;104(6):1263\u201380.","journal-title":"Surg Clin North Am"},{"issue":"5","key":"5407_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cancers14051249","volume":"14","author":"ZI Hu","year":"2022","unstructured":"Hu ZI, Lim KH. Evolving paradigms in the systemic treatment of advanced gallbladder cancer: updates in year 2022. Cancers (Basel). 2022;14(5):1249.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5407_CR17","first-page":"50","volume":"10","author":"WQ Che","year":"2023","unstructured":"Che WQ, Li YJ, Tsang CK, et al. How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology. Mil Med Res. 2023;10(1):50.","journal-title":"Mil Med Res"},{"issue":"13","key":"5407_CR18","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1245\/s10434-016-5470-2","volume":"23","author":"S Buettner","year":"2016","unstructured":"Buettner S, Margonis GA, Kim Y, et al. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma. Ann Surg Oncol. 2016;23(13):4401\u20139.","journal-title":"Ann Surg Oncol"},{"key":"5407_CR19","doi-asserted-by":"publisher","first-page":"106234","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, et al. Current management of incidental gallbladder cancer: A review. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg"},{"key":"5407_CR20","doi-asserted-by":"publisher","first-page":"e934447","DOI":"10.12659\/MSM.934447","volume":"28","author":"J Xie","year":"2022","unstructured":"Xie J, Liao Z, Sun C, et al. Impact of Primary Tumor Resection on Survival of Patients with Metastatic Gallbladder Carcinoma: A Population-Based, Propensity\u2013Matched Study. Med Sci Monit. 2022;28:e934447.","journal-title":"Med Sci Monit"},{"issue":"1","key":"5407_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4251\/wjgo.v16.i1.13","volume":"16","author":"ET Pavlidis","year":"2024","unstructured":"Pavlidis ET, Galanis IN, Pavlidis TE. New trends in diagnosis and management of gallbladder carcinoma. World J Gastrointest Oncol. 2024;16(1):13\u201329.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"5407_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12885-019-6507-2","volume":"20","author":"K Yuza","year":"2020","unstructured":"Yuza K, Sakata J, Prasoon P, et al. Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation. BMC Cancer. 2020;20(1):20.","journal-title":"BMC Cancer"},{"issue":"2","key":"5407_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.21873\/invivo.12372","volume":"35","author":"R Matsuyama","year":"2021","unstructured":"Matsuyama R, Matsuo K, Mori R, et al. Incidental Gallbladder Cancer on Cholecystectomy: Strategy for Re-resection of Presumed Benign Diseases from a Retrospective Multicenter Study by the Yokohama Clinical Oncology Group. Vivo. 2021;35(2):1217\u201325.","journal-title":"Vivo"},{"issue":"3","key":"5407_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.surg.2017.05.004","volume":"162","author":"W Lee","year":"2017","unstructured":"Lee W, Jeong CY, Jang JY, et al. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study. Surgery. 2017;162(3):515\u201324.","journal-title":"Surgery"},{"issue":"1","key":"5407_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12957-018-1556-6","volume":"17","author":"JK Cho","year":"2019","unstructured":"Cho JK, Lee W, Jang JY, et al. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study. World J Surg Oncol. 2019;17(1):8.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"5407_CR26","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s13304-022-01302-9","volume":"74","author":"T Gao","year":"2022","unstructured":"Gao T, Tang H, Zhou B, et al. Can patients with gallbladder adenocarcinoma and liver metastases obtain survival benefit from surgery? A population-based study. Updates Surg. 2022;74(4):1353\u201366.","journal-title":"Updates Surg"},{"issue":"7","key":"5407_CR27","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.ejso.2022.03.013","volume":"48","author":"M Goel","year":"2022","unstructured":"Goel M, Pandrowala S, Patel P, et al. Node positivity in T1b gallbladder cancer: A high volume centre experience. Eur J Surg Oncol. 2022;48(7):1585\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"5407_CR28","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1002\/cam4.2989","volume":"9","author":"L Xu","year":"2020","unstructured":"Xu L, Tan H, Liu X, et al. Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013). Cancer Med. 2020;9(11):3668\u201379.","journal-title":"Cancer Med"},{"issue":"4","key":"5407_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.14701\/ahbps.2019.23.4.403","volume":"23","author":"M Prieto","year":"2019","unstructured":"Prieto M, Gastaca M, Ruiz P, et al. Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection. Ann Hepatobiliary Pancreat Surg. 2019;23(4):403\u20137.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"4","key":"5407_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/13543784.2021.1854724","volume":"30","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Ricci AD, Bonucci C, et al. Experimental HER2- targeted therapies for biliary tract cancer. Expert Opin Investig Drugs. 2021;30(4):389\u201399.","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"5407_CR31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","volume":"33","author":"M Maio","year":"2022","unstructured":"Maio M, Ascierto PA, Manzyuk L, et al. Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study. Ann Oncol. 2022;33(9):929\u201338.","journal-title":"Ann Oncol"},{"issue":"1","key":"5407_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12893-021-01068-8","volume":"21","author":"Y Yang","year":"2021","unstructured":"Yang Y, Tu Z, Ye C, et al. Site-specific metastases of gallbladder adenocarcinoma and their prognostic value for survival: a SEER-based study. BMC Surg. 2021;21(1):59.","journal-title":"BMC Surg"},{"issue":"16","key":"5407_CR33","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3748\/wjg.v29.i16.2369","volume":"29","author":"J Sun","year":"2023","unstructured":"Sun J, Xie TG, Ma ZY, et al. Current status and progress in laparoscopic surgery for gallbladder carcinoma. World J Gastroenterol. 2023;29(16):2369\u201379.","journal-title":"World J Gastroenterol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05407-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05407-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:48:27Z","timestamp":1788270507000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05407-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5407"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05407-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1284"}}